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Sex	differences	in	hypothalamic‐pituitary‐adrenal	(HPA)	axis	activity	are	well	estab‐
lished	in	rodents.	In	addition	to	glucocorticoids,	stress	also	stimulates	the	secretion	
of	progesterone	and	deoxycorticosterone	(DOC)	from	the	adrenal	gland.	Neuroactive	
steroid	metabolites	of	these	precursors	can	modulate	HPA	axis	function;	however,	it	
is not known whether levels of these steroids differ between male and females fol‐
lowing	stress.	In	the	present	study,	we	aimed	to	establish	whether	neuroactive	ster‐
oid	concentrations	in	the	brain	display	sex‐	and/or	region‐specific	differences	under	
basal	conditions	and	following	exposure	to	acute	stress.	Brains	were	collected	from	
male	 and	 female	 rats	 killed	 under	 nonstress	 conditions	 or	 following	 exposure	 to	
forced	swimming.	Liquid	chromatography‐mass	spectrometry	was	used	to	quantify	
eight	steroids:	corticosterone,	DOC,	dihydrodeoxycorticosterone	(DHDOC),	pregne‐
nolone,	progesterone,	dihydroprogesterone	(DHP),	allopregnanolone	and	testoster‐
one	in	plasma,	and	in	five	brain	regions	(frontal	cortex,	hypothalamus,	hippocampus,	
amygdala	 and	 brainstem).	 Corticosterone,	 DOC	 and	 progesterone	 concentrations	
were	 significantly	 greater	 in	 the	 plasma	 and	 brain	 of	 both	 sexes	 following	 stress;	
however,	the	responses	in	plasma	were	greater	in	females	compared	to	males.	This	
sex	difference	was	also	observed	in	the	majority	of	brain	regions	for	DOC	and	pro‐
gesterone	but	not	for	corticosterone.	Despite	observing	no	stress‐induced	changes	
in	circulating	concentrations	of	pregnenolone,	DHDOC	or	DHP,	concentrations	were	
significantly greater in the brain and this effect was more pronounced in females 
than	males.	Basal	plasma	and	brain	concentrations	of	allopregnanolone	were	signifi‐
cantly	higher	in	females;	moreover,	stress	had	a	greater	impact	on	central	allopregna‐
nolone	 concentrations	 in	 females.	 Stress	 had	 no	 effect	 on	 circulating	 or	 brain	
concentrations	of	testosterone	in	males.	These	data	indicate	the	existence	of	sex	and	
regional differences in the generation of neuroactive steroids in the brain following 
acute	stress,	especially	for	the	5α‐reduced	steroids,	and	further	suggest	a	sex‐spe‐
cific	expression	of	steroidogenic	enzymes	in	the	brain.	Thus,	differential	neurosteroi‐
dogenesis	may	contribute	to	sex	differences	in	HPA	axis	responses	to	stress.
K E Y W O R D S
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1  | INTRODUC TION
Steroid	hormones	play	a	crucial	 role	 in	regulating	physiological	 re‐
sponses	to	stress.	They	can	exert	their	actions	in	target	tissues	by	
binding	 to	classical	 steroid	 receptors,	which	 then	act	as	 transcrip‐
tion	 factors	 in	 the	 nucleus	 to	 alter	 gene	 expression.	 Additionally,	
steroids	can	act	in	a	nonclassical	manner.	Neuroactive	steroids	are	
active	metabolites	of	classical	steroid	hormones	that,	 independent	
of	 their	 source	 (ie,	 peripheral	 or	 central),	 exert	 rapid	 nongenomic	
effects	on	neuronal	excitability	by	binding	to	membrane	bound	ion	
channel‐linked	receptors,	thus	 influencing	neurotransmission.1 The 
brain	itself	can	produce	neuroactive	steroids	(referred	to	as	“neuros‐
teroids”),	via	local	de	novo	synthesis	from	cholesterol	or	through	the	
conversion of peripherally derived adrenal or gonadal steroids.1,2 In 
support	of	 this,	 the	brain	possesses	many	 steroidogenic	 enzymes,	
including 5α‐reductase	 and	 3α‐hydroxysteroid	 dehydrogenase	
(3αHSD)	which	 are	not	only	mainly	 expressed	by	glial	 cells,3‐5 but 
also found in neurones.6	 Furthermore,	 neurosteroids	 continue	 to	
be detected in the brain after combined adrenalectomy and go‐
nadectomy,7 providing evidence for local neurosteroidogenesis. 
Nevertheless,	the	synthesis	of	neurosteroids	is	reliant	upon	the	ex‐
pression	of	 the	 prerequisite	 steroidogenic	 enzymes,	which	 exhibit	
significant regional differences in the brain.8
The major neuroendocrine response to stress is mediated via 
activation	 of	 the	 hypothalamic‐pituitary‐adrenal	 (HPA)	 axis,	which	
results in a net increase in circulating glucocorticoids following ac‐
tivation	 of	 corticotrophin‐releasing	 hormone	 (CRH)	 neurones	 in	
the	medial	 parvocellular	 paraventricular	 nucleus	 (mpPVN)	 and	 ad‐
renocorticotrophic	 hormone	 (ACTH)	 secretion	 from	 the	 anterior	
pituitary.	Glucocorticoids,	synthesised	in	the	adrenal	cortex,	act	at	
multiple targets in the body to facilitate the necessary metabolic 
and	behavioural	adaptations	required	for	stress	coping	and	restoring	
physiological	homeostasis.	Moreover,	glucocorticoids	provide	neg‐
ative‐feedback	 control	 of	 the	HPA	 axis	 through	 actions	 on	 gluco‐
corticoid	and	mineralocorticoid	receptors	in	the	brain	and	pituitary,	
crucial for terminating the stress response.
In	 addition	 to	 glucocorticoids,	 stress	 also	 results	 in	 a	 rapid	 in‐
crease in the secretion of other steroid hormones such as progester‐
one9	and	11‐deoxycorticosterone	(DOC)10	from	the	adrenal	cortex.	
In	the	brain,	these	steroids	can	be	further	metabolised	into	neuro‐
active	 steroids,	 such	 as	 5α‐dihydroprogesterone	 (DHP)	 and	5α‐di‐
hydrodeoxycorticosterone	(DHDOC)	by	5α‐reductase,	which	in	turn	
may	be	 converted	 into	 allopregnanolone	 and	 tetrahydrodeoxycor‐
ticosterone	(THDOC),	respectively,	by	3αHSD	(Figure	1),	which	are	
considered	 to	 fine‐tune	 and	 aid	 cessation	 of	 the	 stress	 response.	
Indeed,	levels	of	both	allopregnanolone	and	THDOC	are	increased	
in	the	cerebral	cortex	and	hypothalamus	following	exposure	to	acute	
stress11	and	both	have	been	shown	to	negatively	modulate	stress‐
induced	HPA	axis	activity	 in	vivo.12‐15	Moreover,	allopregnanolone	
prevents	 the	 up‐regulation	 of	CRH	mRNA	 in	 the	mpPVN	 induced	
by	 adrenalectomy,	 attenuates	 stimulated	CRH	 release	 from	 hypo‐
thalamic	explants	and	 inhibits	 the	 firing	of	mpPVN	CRH	neurones	
in vitro16,17,	while	administration	of	the	5α‐reductase	inhibitor,	fin‐
asteride,	leads	to	heightened	HPA	axis	responses	to	stress	in	males	
and females.13,18	Allopregnanolone,	DHDOC	and	THDOC	are	pos‐
itive	 allosteric	modulators	of	GABAA receptors; by prolonging the 
opening	time	of	chloride	ion	channels	within	GABAA	receptors,	they	
enhance	the	inhibitory	actions	of	GABA.19‐22	Given	that	the	PVN	is	
substantially	innervated	by	GABAergic	neurones23,24 and the major‐
ity	of	mpPVN	CRH	neurones	express	GABAA	receptors,
25 this pro‐
vides a means by which local neurosteroids may modulate inhibitory 
tone	over	the	HPA	axis.
F I G U R E  1  Biosynthetic	pathways	involved	in	steroidogenesis.	The	major	pathways	and	enzymes	involved	in	the	biosynthesis	of	
corticosteroids,	progestogens,	androgens	and	oestrogens	from	cholesterol.	3α‐diol,	3α‐androstanediol;	3αHSD,	3α‐hydroxysteroid	
dehydrogenase	(Akr1c);	3β‐diol,	3β‐androstanediol;	3‐βHSD,	3β‐hydroxysteroid	dehydrogenase	(Hsd3b);	5αR,	5α‐reductase	(Srd5a);	
17αHSD,	17α‐hydroxysteroid	dehydrogenase	(Hsd17a);	17βHSD,	17β‐hydroxysteroid	dehydrogenase	(Hsd17b);	DHDOC:	5α‐
dihydrodeoxycorticosterone;	DHEA,	dehydroepiandrosterone;	DHP,	5α‐dihydroprogesterone;	DHT,	5α‐dihydrotestosterone;	DOC,	11‐
deoxycorticosterone;	p450scc,	cholesterol	side‐chain	cleavage	enzyme	(Cyp11a1);	THDOC,	tetrahydrodeoxycorticosterone
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It	is	well	established	that	there	are	sex	differences	in	both	basal	
and	 stress‐induced	 activity	 of	 the	 HPA	 axis	 in	 rodents.	 Females	
generally display greater concentrations of circulating corticoste‐
rone under nonstress conditions and this is particularly evident at 
the onset of the dark phase.26,27	 In	addition,	 the	HPA	axis	 is	more	
responsive	to	both	physical	and	psychological	stressors	in	females,	
than	males,	 as	 reflected	 by	 greater	 secretion	 of	 ACTH	 and	 corti‐
costerone	 and	 a	 larger	 increase	 in	 CRH	 gene	 transcription	 in	 the	
mpPVN.27‐31
Intriguingly,	stress‐induced	activation	of	neurones	in	limbic	brain	
regions,	such	as	the	prefrontal	cortex	and	hippocampus,	 is	greater	
in males than in females.32‐34	Given	 that	 these	 regions	project	 in‐
directly	 to	 the	PVN	 (eg	 via	 a	 relay	 in	 the	bed	nucleus	of	 the	 stria	
terminalis)	and	exert	a	net	inhibitory	effect	on	HPA	axis	activity,35‐37 
lower stress responses in males may reflect greater inhibitory signal‐
ling	from	limbic	brain	regions	to	the	PVN.
The	 sex	 differences	 in	HPA	 axis	 activity	 have	 been	 largely	 at‐
tributed	to	gonadal	steroids,	given	that	oestradiol	typically	has	stim‐
ulatory	actions,	whereas	androgens	have	inhibitory	effects	on	HPA	
axis	 function.	 For	 example,	 ovariectomy	 decreases,38‐40 whereas 
orchidectomy	 increases,27,41‐47	 the	 HPA	 axis	 response	 to	 stress	
and these effects of gonadectomy can be normalised with testos‐
terone41,42,44,46 or oestradiol38	 replacement	 in	males	 and	 females,	
respectively.	However,	 the	effect	of	 testosterone	on	HPA	axis	ac‐
tivity is evidently mediated via the neuroactive metabolite of tes‐
tosterone,	 3β‐androstandiol	 (3β‐diol).48	 Likewise,	 studies	 indicate	
that progesterone may counteract some of the stimulatory effects 
of	oestradiol	on	HPA	axis	activity,49 although this is likely mediated 
via its 3α‐hydroxy	A	ring‐reduced	neuroactive	metabolite,	allopreg‐
nanolone.12,13	Despite	these	findings,	it	is	not	known	whether	there	
are	 sex	differences	 in	 the	 stress‐induced	neuroactive	 steroid	 con‐
centrations	 in	 the	brain,	which	 could	potentially	 contribute	 to	 the	
differential	HPA	axis	responses	in	males	and	females.
Although	some	studies	have	quantified	the	concentrations	of	a	
few	steroids	in	the	brain	in	response	to	foot‐shock,	forced	swimming	
or CO2	inhalation,	previous	work	has	focused	on	males	and	measure‐
ments	have	been	largely	limited	to	the	cerebral	cortex	or	hypothal‐
amus.11,50‐52 In studies where male and females have been directly 
compared,	this	has	been	under	nonstress	conditions.53,54	To	date,	no	
study	has	 simultaneously	measured	 stress‐induced	 concentrations	
of	multiple	steroids	in	several	different	brain	regions.	Moreover,	to	
the	best	of	our	knowledge,	no	study	has	compared	changes	in	cen‐
tral steroid levels in response to stress in male and female rats in 
the	same	experiment.	Traditional	detection	methods	such	as	radio‐
immunoassays	 incur	 limitations:	 cross‐reactivity	 issues	may	hinder	
accuracy,	whereas	low	throughput	and	low	sensitivity	makes	quan‐
tification of a panel of structurally related steroids in discrete brain 
regions difficult.55,56
Accordingly,	in	the	present	study,	we	used	a	liquid	chromatogra‐
phy‐mass	spectrometry	(LC‐MS)	method	to	quantify	a	panel	of	ste‐
roids	in	the	plasma,	as	well	as	in	five	separate	brain	regions	known	
to	be	involved	in	regulating	the	activity	of	the	HPA	axis,	from	male	
and female rats under nonstress and acute stress conditions. We 
aimed	to	establish:	(i)	which	steroids	(from	our	panel)	are	increased	
in	the	brain	by	acute	stress;	(ii)	whether	there	are	sex	and/or	regional	
differences	 in	 stress‐induced	 central	 steroid	 concentrations;	 and	
(ii)	whether	circulating	steroid	concentrations	correlate	with	 those	
found in the brain following stress.
2  | MATERIAL S AND METHODS
2.1 | Animals
Male	and	female	Sprague‐Dawley	rats	were	bred	in	the	rodent	facil‐
ity	at	 the	Roslin	 Institute.	Rats	were	group	housed	by	sex	 (four	 to	
six	females,	three	or	four	males	per	cage)	in	open‐top	cages	with	ad	
libitum	access	to	drinking	water	and	a	standard	rodent	diet	(Harlan	
Teklad;	Cambridgeshire,	UK)	and	under	a	12:12	hour	light/dark	cycle	
(lights	on	8.00	am)	with	controlled	temperature	(22±1˚C)	and	humid‐
ity	 (58±3%).	 Experiments	 were	 performed	 in	 rats	 aged	 21	weeks	
and	were	approved	by	the	local	Animal	Welfare	and	Ethical	Review	
Body	and	performed	in	accordance	with	the	UK	Animals	(Scientific	
Procedures)	Act	1986	and	the	European	Directive	(2010/63/EU).
2.2 | Stress paradigm
All	experiments	and	tissue	collection	were	performed	in	male	and	fe‐
male	(randomly	cycling)	rats	between	10.00	am and 12.30 pm. Forced 
swimming	was	 used	 because:	 (i)	 it	 is	 a	 robust	 activator	 of	 the	HPA	
axis57,58;	(ii)	sex	differences	in	ACTH	and	corticosterone	secretion	have	
been demonstrated using this stressor57;	and	(iii)	it	is	a	combined	physi‐
cal	 and	 psychological	 stressor,	 and	 thus	 activates	 stress‐responsive	
nuclei in both the forebrain and hindbrain.59 For the stressed groups 
(n	=	7	per	group	per	sex),	rats	were	placed	in	a	glass	cylinder	(diameter	
25	cm;	height	50	cm)	filled	with	water	(21‐22°C)	to	a	depth	of	30	cm	
and	forced	to	swim	for	2	minutes,	after	which	they	were	gently	dried	in	
a towel and returned to their home cage. Thirty minutes after the onset 
of	swimming	stress,	rats	were	rapidly	transferred	to	a	separate	room	
and	 killed	 by	 conscious	 decapitation.	 This	 time‐point	 has	 previously	
been shown to correspond with peak levels of immediate early gene 
induction59	in	the	brain	and	elevated	corticosterone	secretion,60 as well 
as	with	the	peak	in	stress‐induced	allopregnanolone	concentrations	in	
the brain11,50	following	swim	stress.	For	the	control	group,	rats	(n	=	7	
per	group	per	sex)	remained	undisturbed	in	their	home	cage	prior	to	
killing	(as	before).	In	each	case,	trunk	blood	was	collected	in	tubes	con‐
taining	0.5	mL	of	ice‐cold	5%	(w/v)	EDTA	and	plasma	separated	by	cen‐
trifugation	(1500	g	at	4°C	for	15	minutes).	Brains	were	rapidly	removed,	
and	 the	 regions	 of	 interest	 (frontal	 cortex,	 hypothalamus,	 amygdala,	
hippocampus,	brainstem)	were	dissected	(see	Supporting	information,	
Figure	S1)	and	frozen	on	dry	ice.	Plasma	was	stored	at	−20°C	and	brain	
samples	were	stored	at	−80°C	until	further	analysis.
2.3 | Steroid standards
All	steroid	standards	were	purchased	from	Steraloids	Inc	(Newport,	
RI,	 USA)	 and	 all	 solvents/chemicals	 used	 were	 high‐performance	
4 of 19  |     SZE Et al.
liquid	chromatography	(HPLC)‐MS	grade.	Stock	solutions	of	steroid	
standards	(1	mg	mL‐1)	were	prepared	in	methanol	(Honeywell	Riedel‐
de	 Haën,	 Seelze,	 Germany)	 and	 stored	 at	 −20°C.	 Steroids	 were	
combined and diluted in methanol into a working stock solution con‐
taining a concentration of 10 μg	mL‐1	of	each	steroid	(except	for	allo‐
pregnanolone and progesterone with a concentration of 25 μg	mL‐1).	
On	 the	 day	 of	 sample	 processing,	 standards	were	 further	 diluted	
100‐fold	in	a	surrogate	matrix	4%	(w/v)	bovine	serum	albumin	(BSA)	
(VWR,	Leicester,	UK)	 in	PBS,	 followed	by	a	serial	2.5‐fold	dilution	
in	 4%	BSA	 to	 produce	 seven	 calibrants.	 The	 calibration	 standards	
used	ranged	from	41	to	10	000	pg	mL‐1	for	corticosterone,	DOC	(4‐
pregnen‐21‐ol‐3,20‐dione),	DHDOC	(5α‐pregnan‐21‐ol‐3,20‐dione),	
testosterone,	 pregnenolone	 and	 DHP	 (5α‐pregnane‐3,20‐dione),	
and	102.4	to	25	000	pg	mL‐1 for progesterone and allopregnanolone 
(5α‐pregnan‐3α‐ol‐20‐one).	 The	 deuterated	 internal	 standard	 pro‐
gesterone‐d9	was	also	dissolved	in	methanol	and	diluted	to	a	final	
concentration	of	25	ng	mL‐1	in	50%	methanol.
2.4 | Sample processing
Samples	from	all	four	groups	from	any	given	region	were	processed	
in	the	same	run,	together	with	seven	standard	calibrants	and	a	zero	
sample	containing	only	4%	BSA.	For	standard	calibrants	and	plasma,	
100 μL	was	used.	Frozen	brain	regions	were	weighed	prior	to	sample	
processing	 (n	=	7	per	group	per	 sex,	 except	 for	 the	 frontal	 cortex,	
amygdala and hypothalamus where a sample from the female non‐
stressed	group	was	lost).
2.4.1 | Tissue homogenisation
Brain	samples	were	homogenised	in	500	μL	of	methanol	containing	
1%	 formic	 acid	 (Fisher	 Scientific,	 Loughborough,	 UK).	 For	 plasma	
and	standards,	400	μL	of	methanol	containing	1%	formic	acid	was	
added to 100 μL	of	plasma/standards	and	vigorously	vortexed.	Next,	
20 μL	of	progesterone‐d9	(25	ng	mL‐1)	was	added	and	the	homogen‐
ates	were	briefly	sonicated.	After	incubation	on	dry	ice	for	30	min‐
utes,	the	homogenates	were	centrifuged	for	10	minutes	(13	000	g at 
4°C)	and	the	supernatant	was	decanted	into	a	borosilicate	tube	and	
the	pellet	re‐extracted	again	with	500	μL	of	methanol	containing	1%	
formic	acid,	and	then	sonicated	and	centrifuged	as	described	above	
but	without	incubation.	Supernatants	were	combined,	then	diluted	
with	ultrapure	water	to	a	final	concentration	of	30%	methanol	(see	
Supporting	information,	Figure	S2).
2.4.2 | Solid phase extraction
Steroids	 in	 both	 plasma	 and	 brain	 samples	 were	 extracted	 by	
solid	 phase	 extraction	 using	DSC‐Discovery	 C18	 100	mg	 columns	
(#52602‐U;	 Supelco,	 Belfont,	 PA,	 USA).	 Columns	 were	 activated	
with	1	mL	of	methanol	and	equilibrated	with	another	1	mL	of	30%	
methanol.	Diluted	supernatants	 from	homogenates	 (approximately	
3	mL)	 were	 then	 loaded,	 followed	 by	 two	 1‐mL	 washes	 of	 50%	
methanol.	All	steps	were	assisted	by	centrifugation	at	50	g	(average	
flow	 rate	of	0.5	mL	min‐1).	 Steroids	were	eluted	with	1	mL	of	85%	
methanol by gravity flow. The collected eluate was dried in a vacuum 
concentrator	(Savant	SpeedVac;	ThermoFisher	Scientific,	Waltham,	
MA,	USA)	overnight	(see	Supporting	information,	Figure	S2).	Dried	
samples	were	stored	at	−20°C	until	the	day	of	analysis.
2.4.3 | Derivatisation
On	the	day	of	LC‐MS	analysis,	400	μL	of	freshly	prepared	derivatisa‐
tion	agent	(1	mg	mL‐1	of	Girard’s	T	reagent;	#89397;	Sigma‐Aldrich,	
Gillingham,	UK;	dissolved	in	methanol	containing	0.2%	formic	acid)	
was	added	to	the	dried	samples.	After	incubation	at	37°C	for	30	min‐
utes,	the	reaction	was	stopped	by	the	addition	of	50	μL	of	5%	am‐
monium	 hydroxide	 (ACROS	 Organics,	 Morris	 Plains,	 NJ,	 USA)	 in	
methanol.	Samples	were	dried	in	the	SpeedVac	then	reconstituted	in	
50 μL	of	25	mmol	L‐1	phosphate	buffer	(pH	7.4)	in	50%	methanol	to	
prevent	acid	hydrolysis	of	the	derivatisation	agent	(see	Supporting	
information,	Figure	S2).	The	 sample	was	 transferred	 to	Chromacol	
vials	(ThermoFisher	Scientific)	for	analysis.
2.5 | LC‐MS/MS analysis
Analysis	of	steroids	was	performed	using	an	Ultimate	3000	Dionex	
HPLC	system	coupled	 to	an	AmaZon	ETD	 ion	 trap	mass	spectrom‐
eter	 (Bruker	 Daltonics,	 Bremen,	 Germany).	 Separation	 of	 steroids	
on	reverse	phase	HPLC	was	achieved	on	the	ACE	UltraCore	2.5	μm 
Super	 C18	 column	 (75	mm	 by	 2.1	mm	 inner	 diameter;	 Advance	
Chromatography	Technologies,	Aberdeen,	UK)	maintained	at	40°C.	
Gradient	 elution	 was	 performed	 (see	 Supporting	 information,	
Table	S1)	with	the	mobile	phase	consisting	of	50	mmol	L‐1 ammonium 
formate	 (Thermo	Fisher	 Scientific),	 pH	3	 (solvent	A),	 and	methanol	
with	0.1%	formic	acid	(solvent	B).	Steroids	were	analysed	simultane‐
ously	using	multiple	reaction	monitoring	(see	Supporting	information,	
Table	S2),	with	positive	electrospray	ionisation	and	collision‐induced	
fragmentation.	 Injections	 for	 all	 samples,	 including	 calibrants,	were	
carried out in duplicate. The method allowed us to simultaneously 
determine	 the	 concentrations	 of	 eight	 steroids:	 corticosterone,	
DOC,	DHDOC,	pregnenolone,	progesterone,	DHP,	allopregnanolone	
and	 testosterone	 (Figure	2)	with	 a	 total	 runtime	of	 19	minutes	 (see	
Supporting	 information,	 Table	S1).	 Because	 Girard’s	 T	 reagent	 was	
used	as	the	derivatisation	agent,	only	steroids	with	a	carbonyl	group	
could	be	examined;	thus,	oestradiol	and	the	testosterone	metabolites,	
3α‐	and	3β‐androstanediol,	which	do	not	have	this	functional	group,	
were	not	detected	using	this	method.	THDOC	and	DHT	did	not	pass	
the validation criteria and thus these data are not included.
Data	 were	 acquired	 using	 hystar	 software	 (Bruker	 Daltonics,	
Bremen,	 Germany)	 and	 peak	 area	 under	 the	 curve	was	 extracted	
and automatically integrated using quantanalysis,	version	2.0	(Bruker	
Daltonics).	The	ratio	of	the	peak	area	of	the	target	analyte	and	the	
peak	 area	 of	 progesterone‐d9	was	 used	 to	 construct	 the	 calibra‐
tion	 curve.	 The	 seven‐point	 calibration	 curves	 were	 linear	 for	 all	
analytes	 (see	Supporting	 information,	Table	S3).	Concentrations	of	
samples	were	extrapolated	and	converted	to	ng	mL‐1	(for	plasma)	or	
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normalised	to	the	wet	weight	of	the	tissues	(ng	g‐1;	for	brain	tissues).	
Performance	characteristics	 (ie,	 recovery,	sensitivity,	accuracy	and	
precision)	were	determined	(see	Supporting	information,	Table	S4),	
and the concentrations of steroids detected in the plasma and brain 
were consistent with previous studies.61,62
2.6 | Statistical analysis
Data	are	presented	as	group	means	±	SEM.	In	each	case,	data	were	
compared	using	a	two‐way	ANOVA	(sigmaplot,	version	11.0;	Systat	
Software	Inc.,	Chicago,	IL,	USA),	with	sex	and	stress	as	the	two	main	
factors	followed	by	Student‐Newman	Keuls	pairwise	multiple	com‐
parison	testing,	except	for	the	testosterone	data,	which	were	ana‐
lysed	using	a	two‐tailed	Student’s	t‐test.	The	relationships	between	
circulating and brain concentrations of steroids were determined 
using	Pearson’s	correlation	coefficients	(sigmaplot,	version	11.0),	and	
males	and	females	were	analysed	separately.	In	each	case,	P	≤	0.05	
was considered statistically significant.
3  | RESULTS
3.1 | Corticosterone
3.1.1 | Plasma
As	expected,	there	was	a	main	effect	of	stress	(F1,24	=	58.9,	P	<	0.001)	
and	 sex	 (F1,24	=	54.7,	 P	<	0.001)	 on	 corticosterone	 secretion	 and	
also	 a	 significant	 stress	×	sex	 interaction	 F1,24	=	4.38,	 P	=	0.047).	
Plasma corticosterone concentrations were significantly greater in 
the	 stressed	 group	 compared	 to	 the	 control	 group	 in	 both	 sexes,	
with females displaying significantly greater plasma corticosterone 
concentrations compared to males under both stress and nonstress 
conditions	(Figure	3).
3.1.2 | Brain
There were no significant differences detected in basal corticoster‐
one concentrations between males and females in any of the brain 
regions	 (Figure	3).	There	were	 significant	main	effects	of	 stress	 in	
each	of	the	five	brain	regions	examined	(frontal	cortex,	F1,23	=	50.6,	
P	<	0.001;	 hypothalamus,	 F1,23	=	26.7,	 P	<	0.001;	 amygdala,	
F1,23	=	14.8,	P	<	0.001;	hippocampus,	F1,24	=	45.4,	P < 0.001; brain‐
stem,	 F1,24	=	21.3,	 P	<	0.001),	 with	 corticosterone	 concentrations	
being significantly greater in the stressed rats compared to the non‐
stressed	rats	 in	both	sexes	(Figure	3).	There	was	a	significant	main	
effect	of	sex	observed	only	in	the	brainstem	(F1,24	=	5.30,	P	=	0.03),	
where	 corticosterone	 concentrations	 were	 1.8‐fold	 greater	 in	
stressed females compared to stressed males.
3.1.3 | Correlations between central and circulating 
corticosterone
There were significant positive correlations between corticoster‐
one	concentrations	in	the	plasma	and	in	all	brain	regions,	except	the	
amygdala	in	males	and	the	hypothalamus	in	females	(Table	1).
3.2 | Deoxycorticosterone
3.2.1 | Plasma
There was no significant difference in plasma DOC concentrations 
between	males	 and	 females	under	nonstress	 conditions;	 however,	
F I G U R E  2  Representative	chromatogram	of	the	analytes.	For	some	analytes,	a	double	peak	was	observed	as	a	result	of	the	presence	
of both syn and anti‐Girard's	T	derivatives,	in	which	case	the	major	product	peak	was	used	for	quantification.	The	ratio	between	the	major	
and	minor	peak	was	always	consistent	between	runs.	DHDOC:	5α‐dihydrodeoxycorticosterone;	DHP,	5α‐dihydroprogesterone;	DOC,	11‐
deoxycorticosterone
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there	was	a	significant	effect	of	stress	 (F1,24	=	67.6,	P	<	0.001)	and	
sex	(F1,24	=	26.0,	P	<	0.001)	and	a	significant	stress	×	sex	interaction	
(F1,24	=	20.7,	P	<	0.001).	Stress	resulted	in	significantly	greater	circu‐
lating	DOC	concentrations	in	both	sexes	(Figure	4).	However,	under	
stressed	conditions,	 females	exhibited	 significantly	greater	plasma	
DOC	concentrations	compared	to	males	(Figure	4).
3.2.2 | Brain
There were no differences in basal concentrations of DOC be‐
tween	males	and	females	in	any	of	the	regions	studied	(Figure	4).	
There were significant main effects of stress in all five brain re‐
gions	 (frontal	 cortex:	 F1,23	=	72.0,	 P < 0.001; hypothalamus: 
F1,23	=	37.1,	 P < 0.001; amygdala: F1,23	=	56.7,	 P < 0.001; hip‐
pocampus: F1,24	=	103.1,	 P < 0.001; brainstem: F1,24	=	105.1,	
P	<	0.001).	Central	DOC	concentrations	were	significantly	greater	
in the stressed groups compared to the basal groups for both 
sexes	 (Figure	4).	 There	 were	 additional	 main	 effects	 of	 sex	 ob‐
served	for	the	hippocampus	(F1,24	=	5.34,	P	=	0.03)	and	brainstem	
(F1,24	=	14.4,	P	<	0.001)	and	a	stress	×	sex	interaction	in	the	brain‐
stem	 (F1,24	=	12.9,	 P	=	0.001).	 Comparing	 the	 stressed	 groups,	
females had significantly greater DOC concentrations in the hip‐
pocampus and brainstem compared to males but not in the frontal 
cortex,	hypothalamus	or	amygdala	(Figure	4).
3.2.3 | Correlations between central and 
circulating DOC
There were significant positive correlations between DOC con‐
centrations	 in	 the	plasma	and	all	 five	brain	 regions	 for	both	 sexes	
(Table	1).
3.3 | Dihydrodeoxycorticosterone
3.3.1 | Plasma
There	were	no	significant	differences	in	plasma	DHDOC	concentra‐
tions	in	any	of	the	groups	(Figure	5).
F I G U R E  3  Effect	of	swim	stress	on	corticosterone	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	in	
the	stressed	group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	denote	
significant	sex	differences	within	the	same	stress	status	(#P < 0.05; ###P	<	0.001).	Following	stress,	sex	differences	were	detected	for	
corticosterone	concentrations	in	the	plasma	and	brainstem.	n	=	6‐7	rats	per	group.	Note	the	difference	in	the	scale	of	the	y‐axis	for	plasma
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Steroid Region
Males Females
r P value R P value
Corticosterone Frontal	cortex 0.89 <0.001*** 0.88 <0.001***
Hypothalamus 0.81 <0.001*** 0.55 0.051*
Amygdala 0.51 0.062 0.73 0.005**
Hippocampus 0.82 <0.001*** 0.62 0.017*
Brainstem 0.62 0.019* 0.70 0.006**
DOC Frontal	cortex 0.80 0.001*** 0.90 <0.001***
Hypothalamus 0.76 0.002** 0.75 0.003**
Amygdala 0.75 0.002** 0.85 <0.001***
Hippocampus 0.87 <0.001*** 0.88 <0.001***
Brainstem 0.84 <0.001*** 0.88 <0.001***
DHDOC Frontal	cortex −0.07 0.826 0.23 0.459
Hypothalamus 0.04 0.888 0.60 0.032*
Amygdala 0.80 0.001*** 0.92 <0.001***
Hippocampus 0.19 0.525 0.68 0.008**
Brainstem −0.23 0.427 −0.16 0.591
Pregnenolone Frontal	cortex −0.010 0.738 −0.02 0.942
Hypothalamus 0.14 0.631 0.40 0.170
Amygdala 0.53 0.051* 0.56 0.045*
Hippocampus 0.06 0.828 0.48 0.079
Brainstem −0.25 0.388 −0.15 0.619
Progesterone Frontal	cortex 0.94 <0.001*** 0.90 <0.001***
Hypothalamus 0.98 <0.001*** 0.82 0.001***
Amygdala 0.99 <0.001*** 0.83 <0.001***
Hippocampus 0.94 <0.001*** 0.89 <0.001***
Brainstem 0.93 <0.001*** 0.88 <0.001***
DHP Frontal	cortex 0.17 0.571 0.18 0.552
Hypothalamus −0.28 0.342 0.50 0.086
Amygdala 0.83 <0.001*** 0.94 <0.001***
Hippocampus 0.01 0.747 0.66 0.011*
Brainstem −0.20 0.491 0.11 0.710
Allopregnanolone Frontal	cortex −0.03 0.918 −0.02 0.952
Hypothalamus 0.04 0.907 0.35 0.246
Amygdala 0.59 0.026* 0.54 0.055
Hippocampus 0.43 0.127 0.35 0.227
Brainstem 0.41 0.143 −0.11 0.710
Testosterone Frontal	cortex 0.81 <0.001***
Hypothalamus 0.89 <0.001***
Amygdala 0.47 0.094
Hippocampus 0.49 0.075
Brainstem 0.80 0.001***
Pearson’s	correlation	coefficient	(r)	and	probability	(P)	values	between	plasma	and	brain	concentra‐
tions of steroids. Males and females were analysed separately and data from both stressed and 
nonstressed	groups	within	the	same	sex	were	used	for	analysis	(n	=	13‐14	per	sex).
Asterisks	denote	significant	correlations	with	plasma	concentrations	(*P	≤	0.05;	**P	≤	0.01;	***P	≤	
0.001).
TA B L E  1   Correlation between central 
and circulating steroids
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3.3.2 | Brain
There	were	significant	main	effects	of	stress	in	all	brain	regions,	ex‐
cept	for	the	amygdala	(frontal	cortex,	F1,23	=	16.1,	P < 0.001; hypo‐
thalamus,	F1,23	=	8.46,	P	=	0.008;	hippocampus,	F1,24	=	7.67,	P	=	0.01;	
brainstem,	F1,24	=	5.68,	P	=	0.025)	(Figure	5).	There	were	significant	
main	 effects	of	 sex	on	DHDOC	concentrations	 in	 the	 frontal	 cor‐
tex	 (F1,23	=	6.09,	 P	=	0.02)	 and	 brainstem	 (F1,24	=	4.35,	 P	=	0.048).	
In	the	frontal	cortex,	DHDOC	concentrations	were	greater	in	both	
the stressed males and females compared to their respective con‐
trol	 groups,	with	 stress‐induced	 concentrations	 being	 significantly	
greater	 in	females	compared	to	males.	However,	 in	the	hypothala‐
mus,	hippocampus	and	brainstem,	stress	resulted	in	greater	DHDOC	
concentrations only in females.
3.3.3 | Correlations between central and 
circulating DHDOC
In	males,	only	the	DHDOC	concentration	in	the	amygdala	was	cor‐
related	with	plasma	levels,	whereas,	in	females,	there	were	positive	
correlations	 between	 DHDOC	 concentrations	 in	 the	 plasma	 and	
those	in	the	amygdala,	hippocampus	and	hypothalamus	(Table	1).
3.4 | Pregnenolone
3.4.1 | Plasma
There were no significant differences in plasma pregnenolone con‐
centrations	between	any	of	the	groups	(Figure	6).
F I G U R E  4  Effect	of	swim	stress	on	DOC	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	in	the	stressed	
group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	denote	significant	sex	
differences	with	the	same	stress	status	(#P < 0.05; ##P < 0.01; ###P	<	0.001).	After	stress	exposure,	sex	differences	were	detected	for	DOC	
concentrations	in	the	plasma,	hippocampus	and	brainstem.	n	=	6‐7	rats	per	group
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3.4.2 | Brain
There	 was	 a	 significant	 main	 effect	 of	 sex	 (frontal	 cortex,	
F1,23	=	5.44,	 P	=	0.029;	 hypothalamus,	 F1,23	=	7.75,	 P	=	0.01;	 amyg‐
dala,	 F1,23	=	20.2,	 P < 0.001; hippocampus F1,24	=	27.3,	 P < 0.001; 
brainstem,	 F1,24	=	19.1)	 and	 stress	 (frontal	 cortex,	 F1,23	=	39.2,	
P	<	0.001;	 hypothalamus,	 F1,23	=	10.4,	 P	=	0.004;	 amygdala,	
F1,23	=	40.9,	P < 0.001; hippocampus; F1,24	=	39.9,	P < 0.001; brain‐
stem,	 F1,24	=	26.7)	 in	 all	 of	 the	 brain	 regions	 examined	 (Figure	6).	
There	was	also	a	significant	sex	×	stress	interaction	in	the	brainstem	
(F1,24	=	4.89),	 amygdala	 (F1,23	=	12.8,	 P	=	0.002)	 and	 hippocampus	
(F1,24	=	7.25,	P	=	0.01).	There	was	no	difference	in	basal	levels	of	preg‐
nenolone	in	the	brain	between	the	sexes	(Figure	6).	Following	stress,	
both males and females had greater pregnenolone concentrations 
than	their	respective	control	groups	in	all	brain	regions,	except	for	
the	hypothalamus,	where	only	females	showed	significantly	greater	
pregnenolone concentrations compared to nonstressed females. For 
each	brain	region	examined,	stress‐induced	pregnenolone	concen‐
trations	were	greater	in	females	versus	males	(Figure	6).
3.4.3 | Correlations between central and circulating 
pregnenolone
For	 both	males	 and	 females,	 the	 only	 significant	 correlation	 ob‐
served with plasma concentrations of pregnenolone was in the 
amygdala	(Table	1).	No	other	significant	correlations	were	detected	
between circulating and brain pregnenolone concentrations.
3.5 | Progesterone
3.5.1 | Plasma
There	were	significant	main	effects	of	stress	(F1,24	=	49.1,	P	<	0.001)	
and	 sex	 (F1,24	=	49.7,	 P	<	0.001)	 and	 also	 a	 significant	 stress	×	sex	
F I G U R E  5  Effect	of	swim	stress	on	DHDOC	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	in	the	
stressed	group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01);	hashes	denote	significant	sex	
differences	within	the	same	stress	status	(#P	<	0.05).	Following	stress,	there	was	a	significant	sex	difference	in	the	frontal	cortex	and	a	
tendency	towards	greater	DHDOC	concentrations	in	the	brainstem	of	stressed	females	compared	to	stressed	males	(P	=	0.068).	n	=	6‐7	rats	
per	group.	Note	the	difference	in	the	scaling	of	the	y‐axis	for	the	hypothalamus	and	brainstem
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interaction	(F1,24	=	10.8,	P	=	0.003)	in	plasma	progesterone	concen‐
trations.	Under	basal	 conditions,	 circulating	progesterone	was	 sig‐
nificantly	greater	 in	 females	compared	to	males	 (Figure	7).	 In	both	
sexes,	 stress	 resulted	 in	 increased	 progesterone	 secretion,	 with	
greater	circulating	concentrations	in	females	than	in	males	(Figure	7).
3.5.2 | Brain
There	were	significant	main	effects	of	stress	and	sex	in	all	five	brain	
regions	 examined	 (frontal	 cortex:	 stress	 F1,23	=	62.6,	 P < 0.001 
and	 sex	 F1,23	=	13.6,	 P	=	0.001;	 hypothalamus:	 stress	 F1,23	=	48.3,	
P	<	0.001	 and	 sex	 F1,23	=	28.7,	 P < 0.001; amygdala: stress 
F1,23	=	50.7,	P	<	0.001	and	sex	F1,23	=	23.0,	P < 0.001; hippocampus: 
stress F1,24	=	53.9,	P	<	0.001	and	 sex	F1,24	=	38.9,	P < 0.001; brain‐
stem: stress F1,24	=	31.9	and	sex	F1,24	=	18.8).	There	were	also	stress	
×	 sex	 interactions	 observed	 for	 the	 hypothalamus	 (F1,23	=	8.14,	
P	=	0.009),	 amygdala	 (F1,23	=	4.48,	 P	=	0.045)	 and	 hippocampus	
(F1,24	=	3.94,	P	=	0.058).	There	was	a	tendency	for	higher	basal	pro‐
gesterone	concentrations	 in	 females	compared	to	males;	however,	
this	was	only	statistically	significant	in	the	hippocampus	(Figure	7).	
Following	 stress,	 progesterone	 concentrations	 in	 all	 five	 brain	 re‐
gions were significantly higher than those measured under basal 
conditions	 in	 both	 sexes.	 Moreover,	 in	 each	 case,	 stress‐induced	
progesterone concentrations were greater in females than in males 
(Figure	7).
3.5.3 | Correlations between central and circulating 
progesterone
There were significant positive correlations between circulating pro‐
gesterone concentrations and those measured in all five brain re‐
gions	for	both	males	and	females	(Table	1).
F I G U R E  6  Effect	of	swim	stress	on	pregnenolone	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	in	
the	stressed	group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	denote	
significant	sex	differences	with	the	same	stress	status	(#P < 0.05; ##P < 0.01; ###P	<	0.001).	Concentrations	of	pregnenolone	were	greater	in	
stressed	females	vs	the	stressed	males	in	all	of	the	brain	regions	examined.	n	=	6‐7	rats	per	group.	Note	the	difference	in	the	scaling	of	the	
y‐axis	for	the	hypothalamus	and	brainstem
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3.6 | Dihydroprogesterone
3.6.1 | Plasma
There	was	no	significant	difference	in	circulating	DHP	in	any	of	the	
groups	investigated	(Figure	8).
3.6.2 | Brain
There	was	a	significant	main	effect	of	stress	on	DHP	concentration	in	
the	frontal	cortex	(F1,23	=	13.1,	P	=	0.001),	hypothalamus	(F1,23	=	7.14,	
P	=	0.01),	amygdala	(F1,23	=	5.73,	P	=	0.03),	hippocampus	(F1,24	=	9.77,	
P	=	0.005)	and	brainstem	 (F1,24	=	22.0,	P	<	0.001),	as	well	as	a	main	
effect	of	sex	for	the	hypothalamus	(F1,23	=	24.0,	P	<	0.001)	and	brain‐
stem	(F1,24	=	16.0,	P	<	0.001).	Under	basal	conditions,	DHP	concen‐
trations in the hypothalamus were significantly greater in females 
than in males and there was a similar trend observed for the brainstem 
(P	=	0.06)	(Figure	8).	Following	stress,	females	had	significantly	higher	
DHP	in	each	of	the	brain	regions	investigated	compared	to	nonstress	
conditions,	whereas,	in	males,	stress‐induced	concentrations	of	DHP	
were	greater	than	basal	levels	only	in	the	frontal	cortex	and	brainstem	
(Figure	8).	There	was	a	sex	difference	in	stress‐induced	DHP	concen‐
trations,	with	stressed	females	exhibiting	greater	DHP	than	stressed	
males	in	the	amygdala,	hypothalamus	and	brainstem	(Figure	8).
3.6.3 | Correlations between central and 
circulating DHP
There	were	significant	positive	correlations	observed	between	DHP	
concentrations in the amygdala and circulation in both males and fe‐
males	(Table	1).	In	females,	there	was	also	a	modest	correlation	be‐
tween	the	DHP	concentrations	in	the	plasma	and	the	hippocampus	
(Table	1).	No	other	correlations	were	detected	between	central	and	
circulating	DHP	levels.
F I G U R E  7  Effect	of	swim	stress	on	progesterone	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	
in	the	stressed	group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	
denote	significant	sex	differences	within	the	same	stress	status	(#P < 0.05; ##P < 0.01; ###P	<	0.001).	Following	stress,	sex	differences	in	
progesterone	concentrations	were	detected	in	the	plasma	and	all	regions	of	the	brain.	n	=	6‐7	rats	per	group.	Note	the	difference	in	the	
scaling of the y‐axis	for	the	brainstem
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3.7 | Allopregnanolone
3.7.1 | Plasma
There	was	an	effect	of	sex	on	circulating	allopregnanolone	concen‐
trations	(F1,24	=	21.9,	P	<	0.001).	Basal	allopregnanolone	concentra‐
tions	were	significantly	greater	 in	females	than	 in	males	 (Figure	9).	
There was no main effect of stress on plasma allopregnanolone con‐
centrations	in	either	sex	(Figure	9).
3.7.2 | Brain
There	were	 significant	main	 effects	 of	 sex	 on	 allopregnanolone	
concentrations	for	each	of	the	brain	regions	examined	(frontal	cor‐
tex,	F1,23	=	14.9,	P	<	0.001;	hypothalamus,	F1,23	=	13.1,	P	=	0.001;	
amygdala,	 F1,23	=	80.2,	 P	<	0.001;	 hippocampus,	 F1,24	=	20.9,	
P	<	0.001;	 brainstem,	F1,24	=	40.2,	P	<	0.001).	 A	 significant	main	
effect of stress was observed for allopregnanolone concen‐
trations	 in	 the	 frontal	 cortex	 (F1,23	=	5.71,	 P	=	0.03),	 amygdala	
(F1,23	=	27.6,	P	<	0.001)	and	brainstem	(F1,24	=	9.08,	P	=	0.006).	A	
stress	×	sex	 interaction	 was	 additionally	 observed	 in	 the	 amyg‐
dala	 (F1,23	=	14.8,	P	<	0.001).	 Basal	 allopregnanolone	 concentra‐
tions were significantly greater in females than in males in all of 
the	brain	regions,	except	the	hypothalamus,	where	a	tendency	for	
higher	 levels	 was	 observed	 (P	=	0.07)	 (Figure	9).	 Stress	 resulted	
in significantly greater allopregnanolone concentrations in the 
frontal	cortex,	amygdala	and	brainstem	compared	to	nonstressed	
females	(Figure	9).	Similar	trends	were	observed	in	the	male	brain,	
although this only reached statistical significance for the frontal 
cortex.
F I G U R E  8  Effect	of	swim	stress	on	DHP	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	in	the	stressed	
group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	denote	significant	sex	
differences	within	the	same	stress	status	(#P < 0.05; ##P	<	0.01).	Under	nonstress	conditions,	DHP	concentrations	were	greater	in	the	
hypothalamus	of	females	compared	to	males	and	a	similar	trend	was	detected	in	the	brainstem	(P	=	0.06).	Following	stress,	significant	sex	
differences	in	DHP	concentrations	were	detected	in	the	hypothalamus,	amygdala	and	brainstem.	n	=	6‐7	rats	per	group.	Note	the	difference	
in the scaling of the y‐axis	for	the	brainstem
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3.7.3 | Correlations between central and circulating 
allopregnanolone
In	both	sexes,	only	allopregnanolone	concentrations	in	the	amygdala	
were found to be significantly correlated with circulating allopregna‐
nolone	(Table	1).
3.8 | Testosterone
3.8.1 | Plasma
There was no significant effect of stress on plasma testosterone 
concentrations	 in	males	(1.05	±	0.28	ng	mL‐1 in nonstressed rats vs 
0.77	±	0.20	ng	mL‐1	 in	 stressed	 rats).	 Testosterone	 was	 below	 the	
lower	limit	of	quantification	(ie	<41	pg	mL‐1)	 in	the	plasma	from	fe‐
males	(see	Supporting	information,	Table	S4).
3.8.2 | Brain
Testosterone	was	below	the	lower	limit	of	quantification	in	all	of	the	brain	
regions in females. There was no significant effect of stress on central 
testosterone	concentrations	 in	male	 rats	 (frontal	 cortex,	2.20	±	0.45	
vs	2.20	±	0.58	ng	g‐1;	hypothalamus,	2.79	±	0.62	vs	3.15	±	1.23	ng	g‐1; 
amygdala,	0.88	±	0.17	vs	1.03	±	0.24	ng	g‐1;	hippocampus,	1.17	±	0.21	
vs	1.71	±	0.61	ng	g‐1;	brainstem,	2.03	±	0.19	vs	2.90	±	0.35	ng	g‐1 in the 
stressed	and	nonstressed	groups,	respectively).
F I G U R E  9  Effect	of	swim	stress	on	allopregnanolone	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	
in	the	stressed	group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	denote	
significant	sex	differences	with	the	same	stress	status	(#P < 0.05; ##P < 0.01; ###P	<	0.001).	Under	nonstress	conditions,	allopregnanolone	
concentrations	were	greater	in	females	compared	to	males	in	the	plasma	and	each	of	the	brain	regions	examined,	except	the	hypothalamus	
where	there	was	a	tendency	for	higher	levels	in	females	(P	=	0.07).	After	stress	exposure,	significant	sex	differences	in	allopregnanolone	
concentrations	were	detected	in	the	plasma	and	all	regions	of	the	brain.	n/d,	not	detected.	n	=	6‐7	rats/group.	Note	the	difference	in	the	
scaling of the y‐axis	for	the	plasma,	hypothalamus	and	brainstem
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3.8.3 | Correlations between central and circulating 
testosterone
Concentrations	of	testosterone	in	the	frontal	cortex,	amygdala,	hy‐
pothalamus and brainstem were positively correlated with circulat‐
ing	testosterone	in	male	rats	(Table	1).
4  | DISCUSSION
In	the	present	study,	we	investigated	the	impact	of	an	acute	stressor	
on the circulating and central steroid profile in male and female rats. 
Several	key	findings	emerged	in	the	present	study.	We	show	for	the	
first	 time	 there	 are	 clear	 sex	 differences	 in	 the	 brain’s	 steroid	 re‐
sponse	to	acute	swim	stress	in	the	rat,	with	females	typically	show‐
ing markedly greater concentrations in most cases. We also report 
that,	although	concentrations	of	corticosterone,	progesterone	and	
DOC in the brain are positively correlated with those measured in 
the	circulation,	this	is	not	the	case	for	pregnenolone,	DHP,	DHDOC	
and	allopregnanolone,	supporting	the	concept	of	the	de	novo	syn‐
thesis of these neurosteroids in the brain in response to stress.7,11 
Lastly,	 although	 the	effect	of	 stress	on	 the	 steroidal	milieu	of	 the	
brain	was	 largely	 global,	 we	 did	 find	 evidence	 for	 regional	 differ‐
ences	 (Figure	10),	 particularly	 for	 DHDOC	 and	 allopregnanolone,	
which may be of functional relevance.
A	key	 feature	of	 the	endocrine	 response	 to	stress	 is	 increased	
secretion	of	corticosterone	from	the	adrenal	cortex	into	the	blood‐
stream.	It	is	well	established	that	females	display	enhanced	HPA	axis	
activity,	characterised	by	a	greater	circulating	concentrations	of	cor‐
ticosterone	 under	 basal	 conditions	 and	 a	 larger	 increase	 in	ACTH	
and corticosterone secretion following acute stress.63‐65 Consistent 
with	this,	females	 in	the	present	study	exhibited	greater	basal	and	
stress‐induced	plasma	corticosterone	concentrations.	In	the	periph‐
ery,	greater	corticosterone	secretion	in	females	is	associated	with	a	
F I G U R E  1 0  Summary	of	the	key	changes	in	steroid	concentrations	induced	by	stress.	Changes	in	steroid	concentrations	in	the	plasma	
and	brain	30	minutes	after	a	forced	swim	stress.	The	source	of	steroids	in	the	plasma	is	largely	from	peripheral	steroidogenic	organs,	
such	as	the	adrenal	glands	and	gonads,	whereas	steroids	in	the	brain	may	be	peripherally	or	centrally	derived.	Blue	and	red	arrows	
represent	stress‐induced	increases	in	steroid	concentrations	in	males	and	females,	respectively.	Dashes	indicate	no	significant	changes	
following	stress.	Hashes	denote	the	presence	of	a	sex	difference	under	stressed	conditions.	AP,	allopregnanolone;	CORT,	corticosterone;	
DHDOC,	dihydrodeoxycorticosterone;	DHP,	dihydroprogesterone;	DOC,	deoxycorticosterone;	PREG,	pregnenolone;	P4,	progesterone;	T,	
testosterone
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heightened	sensitivity	of	the	anterior	pituitary	to	CRH	and	the	ad‐
renal	gland	to	ACTH,	as	well	as	a	greater	capacity	for	glucocorticoid	
synthesis	in	the	adrenal	glands,66 probably as a result of the actions 
of oestradiol.39	In	the	brain,	CRH	mRNA	expression	in	the	mpPVN	
is	 increased	 following	 stress	 to	 a	 greater	 extent	 in	 females	 than	
in	males,31	which	may	be	 further	 compounded	by	diminished	GR‐
mediated	 negative‐feedback	 control	 of	 the	HPA	 axis	 in	 females.67 
Interestingly,	despite	sex	differences	 in	the	plasma,	corticosterone	
concentrations in the female brain were not different from those 
in	 males,	 except	 for	 in	 the	 brainstem.	 This	 is	 consistent	 with	 the	
finding of similar circadian corticosterone rhythms and concentra‐
tions	in	the	brains	of	males	and	females,	despite	differences	in	the	
plasma.26,27,63,68 It is likely that greater concentrations of corticoste‐
roid‐binding	globulin	(which	restricts	the	amount	of	free	corticoste‐
rone	in	the	blood	that	can	enter	the	brain)	in	females64,69 contribute 
to	this	finding.	It	is	not	known	whether	sex	differences	exist	in	the	
expression	of	11β‐hydroxysteroid	dehydrogenase	type	1	(which	re‐
activates	 corticosterone	 from	 its	 inert	metabolite,	 11‐dehydrocor‐
ticosterone)	in	the	brain,	which	could	play	a	role	in	modulating	the	
local	concentrations	of	corticosterone	in	the	brain.	However,	sex	and	
region‐specific	differences	in	11β‐hydroxylase	(Cyp11b1)	expression	
have	 been	 reported	 in	 the	 brain,70 suggesting that differences in 
local corticosterone synthesis could also potentially contribute.
Under	 nonstress	 conditions,	 circulating	 progesterone	 concen‐
trations	 were	 greater	 in	 females	 than	 males,	 which	 is	 consistent	
with previous findings53,71;	however,	there	was	no	sex	difference	in	
plasma	DOC	 concentrations.	 Following	 stress,	 circulating	 concen‐
trations	 of	 DOC	 and	 progesterone	 were	 increased	 in	 both	 sexes,	
with	significantly	greater	responses	in	females.	Stress	also	resulted	
in	greater	levels	of	progesterone	and	DOC	in	both	sexes	in	each	of	
the	brain	regions	investigated.	Despite	evidence	of	low	levels	of	21‐
hydroxylase	 gene	 expression	 and	 activity	 in	 the	 rodent	 brain,72,73 
DOC is considered to be primarily synthesised from progesterone in 
the	adrenal	cortex	and	is	secreted	from	the	adrenal	glands,	together	
with	progesterone,	in	response	to	stress.9,10 Consistent with this was 
our finding of a positive correlation between circulating DOC and 
progesterone	concentrations	and	those	in	the	brain,	indicating	that	
the likely source of DOC and progesterone in the brain is from the 
periphery,	specifically	adrenal	derived.	Although	there	was	a	robust	
sex	difference	in	circulating	DOC	after	stress,	centrally,	this	was	re‐
flected	only	in	the	brainstem.	This	may	be	a	result	of	sex	differences	
in DOC metabolism in limbic brain regions in females or that circulat‐
ing DOC more readily accesses the brainstem.
Importantly,	DOC	and	progesterone	mediate	rapid	nongenomic	
effects indirectly via their downstream neuroactive metabolites 
THDOC	 and	 allopregnanolone	 (Figure	1),	 which	 act	 as	 allosteric	
modulators	 of	 GABAA receptor activity
1,74 to enhance inhibitory 
GABA	 neurotransmission.	 THDOC	 and	 allopregnanolone	 are	 syn‐
thesised	from	DOC	and	progesterone	via	the	intermediates	DHDOC	
and	DHP,	respectively,	and	their	conversion	is	catalysed	by	the	same	
enzymes:	5α‐reductase	and	3αHSD	(Figure	1).	In	the	present	study,	
stress	resulted	in	higher	concentrations	of	both	DHDOC	and	DHP	
in	discrete	brain	regions	but	not	in	the	plasma,	suggesting	de	novo	
synthesis	of	these	steroids	in	the	brain.	Moreover,	differential	reg‐
ulation	was	 observed	 depending	 on	 sex	 and	 brain	 region.	 For	 ex‐
ample,	DHDOC	concentrations	were	found	to	be	increased	only	in	
the	 frontal	 cortex	of	males	 following	 stress,	whereas,	 for	 females,	
DHDOC	 concentrations	 were	 increased	 in	 the	 frontal	 cortex,	 hy‐
pothalamus,	hippocampus	and	brainstem.	Similarly,	although	stress	
increased	DHP	concentrations	in	each	of	the	five	brain	regions	ex‐
amined	in	females,	in	males,	stress‐induced	elevations	in	DHP	were	
only	detected	in	the	frontal	cortex	and	brainstem.	In	addition	to	the	
presence	of	greater	levels	of	precursors	in	the	female	brain,	differ‐
ential	 expression	 of	 the	 5α‐reductase	 may	 contribute	 to	 the	 sex	
difference,	given	that	expression	has	been	shown	to	be	higher	in	fe‐
males,	at	least	in	the	hippocampus.75	Moreover,	regional	differences	
in	expression	and	activity	have	been	demonstrated	for	5α‐reductase	
and 3α‐HSD	 in	 the	 adult	 brain,76‐79	with	 sexual	 dimorphic	 expres‐
sion	being	displayed	after	 stress	exposure.80	Any	direct	effects	of	
DHDOC	and	DHP	are	unclear,	although	DHP	is	known	to	have	af‐
finity for the progesterone receptor81	and	DHDOC	can	potentiate	
GABA‐activated	 chloride	 ion	 currents	 in	 neurones,22 suggesting 
that,	similar	to	THDOC	and	allopregnanolone,	DHDOC	also	acts	as	a	
positive	allosteric	modulator	at	GABAA receptors.
Roles	for	allopregnanolone	and	THDOC	in	regulating	HPA	axis	
activity in response to stress via potentiating the inhibitory effects 
of	GABA	are	well	established.12‐14,16,74,82,83	Unfortunately,	we	were	
unable	to	reliably	quantify	THDOC	using	our	method;	however,	we	
were	 able	 to	 measure	 allopregnanolone.	 Under	 nonstress	 condi‐
tions,	circulating	and	central	allopregnanolone	concentrations	were	
greater	in	females	than	in	males,	which	is	consistent	with	previous	
findings.54,71 We did not observe a significant increase in circulating 
allopregnanolone	concentrations	30	minutes	 after	 stress	exposure	
in	either	 sex,	 in	 contrast	 to	previous	 studies	 in	male	 rats.11,52 The 
reason	 for	 this	 is	not	clear;	however,	 the	different	duration/inten‐
sity	of	the	swim	stress	used	(2	minutes	in	the	present	study	versus	
10	minutes)	may	contribute.	Moreover,	allopregnanolone	concentra‐
tions	are	known	to	peak	30‐60	minutes	later	in	the	plasma	than	in	
the brain.11	 Nevertheless,	 following	 stress,	 allopregnanolone	 con‐
centrations	were	greater	in	the	frontal	cortex,	amygdala	and	brain‐
stem	of	females	compared	to	controls,	as	well	as	in	the	frontal	cortex	
of	males,	 consistent	with	previous	 findings.11,52	 Sex	differences	 in	
central allopregnanolone concentrations may result from greater 
concentrations	 of	 the	 precursors,	 progesterone	 and	 DHP	 and/
or	sex	differences	in	the	activity	of	the	converting	enzymes	in	the	
brain. The strong positive correlation between central and periph‐
eral	progesterone	concentrations,	coupled	with	a	lack	of	correlation	
between	circulating	and	central	allopregnanolone,	and	its	precursor	
DHP,	 suggests	 that	DHP	 and	 allopregnanolone	 are	 synthesised	 in	
the	brain	from	progesterone	following	stress;	however,	it	would	be	
necessary	to	measure	the	activity	of	the	converting	enzymes	in	the	
brain to confirm this. Caruso et al54 report a positive correlation 
between progesterone concentrations in the plasma and cerebral 
cortex	in	rats,	which	is	consistent	with	our	findings;	however,	in	con‐
trast	 to	 the	present	 study,	 they	also	observed	a	direct	 correlation	
between	 pregnenolone,	 DHP	 and	 allopregnanolone	 levels	 in	 the	
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plasma	and	cerebral	cortex.	The	reason	for	this	difference	is	unclear;	
however,	it	is	important	to	note	that	the	correlations	performed	in	
the present study included data from both stressed and nonstressed 
rats	within	the	same	sex,	whereas,	in	the	previous	study,	correlations	
were analysed only under basal conditions with data from male and 
female	 rats	combined.	Thus,	 it	 is	 likely	 that	 the	 lack	of	correlation	
reported in the present study is a result of stress increasing central 
levels	of	pregnenolone,	DHP	and	allopregnanolone,	without	affect‐
ing circulating levels.
It	 is	not	clear	whether	 the	sex	differences	 in	neurosteroids	re‐
ported in the present study are of functional importance with re‐
spect	 to	 HPA	 axis	 regulation	 and	 further	 studies	 are	 needed	 to	
establish	 whether	 other	 stressors	 result	 in	 similar	 effects.	 Unlike	
the	 brainstem,	 the	 prefrontal	 cortex,	 amygdala	 and	 hippocampus	
do	not	innervate	the	PVN	directly;	rather,	they	modulate	activity	of	
the	HPA	axis	via	neural	projections	to	GABAergic	relay	sites,	such	as	
the	peri‐PVN,	the	bed	nucleus	of	the	stria	terminalis	and	the	medial	
preoptic	 area,	which	 exert	 considerable	 inhibitory	 tone	 over	CRH	
neurones.24,36	 Thus,	 it	 is	 conceivable	 that	 sex	differences	 in	 brain	
concentrations	 of	 neurosteroids	with	GABAA receptor agonist ac‐
tivity may lead to differential modulation of upstream inhibitory sig‐
nalling	pathways,	resulting,	for	example,	in	a	greater	disinhibition	of	
PVN	CRH	neurones	in	females,	which	could	contribute	to	sex	differ‐
ences	in	HPA	axis	responses	to	stress.
As	well	as	the	increase	in	downstream	metabolites	of	progester‐
one	and	DOC,	the	principal	precursor	for	these	steroid	hormones,	
pregnenolone,	 was	 also	 increased	 throughout	 the	 brain	 following	
stress,	 and	 to	 a	 greater	 extent	 in	 the	 brains	 of	 females.	 This	may	
indicate	that,	 in	females,	either	p450scc	is	more	highly	expressed/
more active or that pregnenolone is metabolised at a different rate in 
females;	however,	this	requires	further	study.	Consistent	with	previ‐
ous	studies,	we	found	no	stress‐induced	change	in	plasma	pregnen‐
olone concentrations.52
One point to note is that the females used in the present study 
were	randomly	cycling,	which	may	be	expected	to	influence	the	ste‐
roid	concentrations	 in	 the	brain.	However,	 there	 is	very	 little	vari‐
ation	 in	brain	concentrations	of	pregnenolone,	progesterone,	DHP	
or allopregnanolone across the oestrous cycle when these are mea‐
sured	 in	 the	morning	 (as	 they	were	 in	 the	 present	 study);	 indeed,	
circadian fluctuations in these steroids are far greater than those re‐
lating to any stage of the oestrous cycle.84	Moreover,	oestrous	cycle	
stage does not affect basal corticosterone secretion85 or the corti‐
costerone response to swim stress86 when sampling is performed in 
the morning.
The	 mechanisms	 involved	 in	 stress‐induced	 increases	 in	 neu‐
roactive steroid levels in the brain have yet to be established. One 
study	has	 indicated	 that	CRH	 increases	 concentrations	of	 proges‐
terone,	 DHP	 and	 allopregnanolone	 in	 the	 brain.87	 Steroidogenic	
enzymes	such	as	5α‐reductase	are	known	to	be	regulated	by	andro‐
gens88,89	and,	although	adrenal‐derived	steroids	have	been	shown	to	
increase 3α‐HSD	expression	in	the	brain	in	both	sexes,	gonadal	ste‐
roids regulate central 3α‐HSD	expression	in	a	sex‐specific	manner.90 
Given	that	testosterone	was	unaltered	by	stress,	it	is	unlikely	that	it	
contributes	to	the	rapid	changes	in	stress‐induced	neuroactive	ste‐
roids	seen	in	the	present	study;	however,	testosterone	may	underlie	
sex	differences	in	steroidogenic	enzyme	expression	in	the	brain,	and	
therefore	influence	the	brain’s	capacity	to	produce	neurosteroids.
With	 respect	 to	 rapid	 regulation	 of	 neurosteroid	 production,	
GABA	may	play	a	role	via	an	ultrashort	feedback	loop.	Brain	regions	
that	express	neurosteroidogenic	enzymes	are	densely	innervated	by	
GABAergic	neurones	and	express	abundant	GABAA receptors.
91‐93 
Moreover,	GABA	or	GABAA receptor agonists inhibit the de novo 
synthesis of neurosteroids94 and neurosteroidogenic neurones are 
evidently	under	 tonic	 inhibition	by	GABA.94	Given	that	some	neu‐
roactive	 steroids,	 such	 as	 allopregnanolone,	 are	 potent	 allosteric	
modulators	of	GABAA	receptor	 function,
19‐21 it is conceivable that 
neurosteroids may control their own production by regulating the 
activity	of	GABAA receptors. Whether such a mechanism contrib‐
utes	 to	 the	 sex	differences	 in	 central	 neurosteroid	 concentrations	
requires	further	study;	however,	GABA	receptor	subunit	expression	
does	differ	between	males	and	females,	under	basal	conditions	and	
following stress.95
In	summary,	the	data	obtained	in	the	present	study	demonstrate	
robust	sex	differences	in	the	steroid	response	to	acute	swim	stress	
and	 indicate	 sex‐specific	 expression	 of	 steroidogenic	 enzymes	 in	
the	 brain.	 Taken	 together,	 our	 data	 also	 support	 a	 role	 for	 the	 de	
novo	synthesis	of	neurosteroids	by	the	brain	following	stress,	partic‐
ularly those derived from 5α‐reductase	activity	 (ie,	DHDOC,	DHP,	
allopregnanolone).	The	neurosteroid	 response	 to	 stress	 is	 likely	 to	
be adaptive and disparate neurosteroidogenesis may contribute to 
sex	differences	in	HPA	axis	function;	however,	it	is	unclear	whether	
greater neuroactive steroid levels in females confer an overall ad‐
vantage	 or	 disadvantage.	 Stress‐induced	 increases	 in	 neuroactive	
steroids are likely to have important neuroendocrine and/or be‐
havioural	effects	to	aid	stress	adaptation.	For	example,	 in	addition	
to	modulating	HPA	axis	activity,	allopregnanolone	is	known	to	have	
anxiolytic	 and	analgesic	 actions.82,96	 Sex	differences	 in	 the	brain’s	
response to stress may account for differences in the propensity to 
develop	 stress‐related	 disorders	 between	males	 and	 females,	 fur‐
ther	highlighting	the	importance	of	considering	sex	when	developing	
therapies.
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